INmune Bio Inc
NASDAQ:INMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
INmune Bio Inc
NASDAQ:INMB
|
US |
|
R
|
Ranchero Gold Corp
XTSX:RNCH
|
CA |
|
W
|
Whirlpool SA
BOVESPA:WHRL3
|
BR |
|
Bastide le Confort Medical SA
PAR:BLC
|
FR |
|
My Size Inc
NASDAQ:MYSZ
|
IL |
|
P
|
Postal Savings Bank of China Co Ltd
OTC:PSTVY
|
CN |
|
ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
|
CN |
|
R
|
Richmond Mutual Bancorporation Inc
NASDAQ:RMBI
|
US |
|
P
|
PetroVietnam Power Nhon Trach 2 JSC
VN:NT2
|
VN |
|
Washington H Soul Pattinson and Company Ltd
ASX:SOL
|
AU |
|
Odfjell Drilling Ltd
OSE:ODL
|
BM |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
G
|
GKB Ophthalmics Ltd
BSE:533212
|
IN |
|
M
|
MedNation AG
SWB:EIF
|
DE |
Wall Street
Price Targets
INMB Price Targets Summary
INmune Bio Inc
According to Wall Street analysts, the average 1-year price target for
INMB
is 7.14 USD
with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INMB's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for
INMB
is 7.14 USD
with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
What is INmune Bio Inc's Revenue forecast?
Projected CAGR
589%
The
compound annual growth rate
of INmune Bio Inc's revenue for the next 4 years is
589%.
